WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004094400) SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/094400    International Application No.:    PCT/US2004/009272
Publication Date: 04.11.2004 International Filing Date: 08.04.2004
IPC:
C07D 311/94 (2006.01), C07D 493/04 (2006.01), C07D 495/04 (2006.01)
Applicants: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center, Indianapolis, Indiana 46285 (US) (For All Designated States Except US).
DURST, Gregory, Lee [US/US]; (US) (For US Only).
NORMAN, Bryan, Hurst [US/US]; (US) (For US Only).
PFEIFER, Lance, Allen [US/US]; (US) (For US Only).
RICHARDSON, Timothy, Ivo [US/US]; (US) (For US Only)
Inventors: DURST, Gregory, Lee; (US).
NORMAN, Bryan, Hurst; (US).
PFEIFER, Lance, Allen; (US).
RICHARDSON, Timothy, Ivo; (US)
Agent: SAYLES, Michael, J.; ELI LILLY AND COMPANY, P. O. Box 6288, Indianapolis, Indiana 46206-6288 (US)
Priority Data:
60/464,404 21.04.2003 US
Title (EN) SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS
(FR) BENZOPYRANES SUBSTITUES EN TANT QU'AGONISTES SELECTIFS DU RECEPTEUR BETA DE L'OESTROGENE
Abstract: front page image
(EN)This invention relates to novel heterocycles which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), also referred to as 11CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines. Compounds of the invention have the formula: (I)
(FR)La présente invention concerne de nouveaux dérivés de benzopyrane substitués, des stéréoisomères et des sels pharmaceutiquement acceptables de ceux-ci, ainsi que des procédés pour les préparer. Les composés de l'invention sont utiles en tant qu'agonistes du récepteur $g(b) de l'oestrogène. De tels agonistes sont utiles pour traiter des maladies liées au récepteur $g(b) de l'oestrogène telles que le cancer de la prostate ou BPH.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)